摘要
目的:评价胞必佳( N C W S) 联合全身化疗及单纯全身化疗对恶性胸腔积液的治疗作用。方法:75 例恶性胸腔积液患者随机分为联合组( 胞必佳胸腔内注射加全身化疗) 及单用全身化疗组两组。结果:联合组的有效率为91 .9 % ,优于单用全身化疗组的有效率57 .9 % ( P< 0 .01) 。结论:胞必佳胸腔内注射联合全身化疗优于单纯化疗控制胸水的疗效,值得临床推广应用。
Objective:To evaluate results of N CWS(nocardia rubra cell wall skeleton) treatment through intravenous route or in combination with intrapleural instillation in malignant pleural effusion.Methods:Seventy five cases of malignant pleural effusion were divided at random into intrapleural and intravenous in combination treated group and intravenous alone treated group.Results:The effective rate of intrapleural and intravenous in combination treated group was 91.9% and the effective rate of intravenous alone treated group was 57.9%.The difference between two groups was sigificant( P <0.01).Conclusions:The effect of intrapleural and intravenous treatment of N CWS in combination is better than intravenous treament alone in malignant pleural effusion.Therefore it is a method of choice in clinic.
出处
《蚌埠医学院学报》
CAS
1999年第6期395-396,共2页
Journal of Bengbu Medical College
关键词
胸腔积液
肿瘤
药物疗法
胞必佳
pleural effusion
tumour/chemotherapy
nocardia rubra cell wall skeleton(N CWS)